Cargando…
Development of a Mucoadhesive In Situ Gelling Formulation for the Delivery of Lactobacillus gasseri into Vaginal Cavity
Local administration of vaginal probiotics, especially lactobacilli, has been recently proposed as an effective prevention strategy against candidosis recurrences, which affect 40–50% of women. In this context, the aim of the present work was the development of a mucoadhesive in situ gelling formula...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836057/ https://www.ncbi.nlm.nih.gov/pubmed/31623341 http://dx.doi.org/10.3390/pharmaceutics11100511 |
_version_ | 1783466819335487488 |
---|---|
author | Vigani, Barbara Faccendini, Angela Rossi, Silvia Sandri, Giuseppina Bonferoni, Maria Cristina Grisoli, Pietro Ferrari, Franca |
author_facet | Vigani, Barbara Faccendini, Angela Rossi, Silvia Sandri, Giuseppina Bonferoni, Maria Cristina Grisoli, Pietro Ferrari, Franca |
author_sort | Vigani, Barbara |
collection | PubMed |
description | Local administration of vaginal probiotics, especially lactobacilli, has been recently proposed as an effective prevention strategy against candidosis recurrences, which affect 40–50% of women. In this context, the aim of the present work was the development of a mucoadhesive in situ gelling formulation for the vaginal administration of Lactobacillus gasseri. Mixtures of poloxamer 407 (P407) and methylcellulose (MC), two thermosensitive polymers, were prepared and subjected to rheological analyses for the assessment of their sol/gel transition temperature. The association of P407 (15% w/w) with MC (1.5% w/w) produced an increase in gelation extent at 37 °C even after dilution in simulated vaginal fluid (SVF). The presence of 0.5% w/w pectin (PEC) produced a reduction of vehicle pH and viscosity at 25 °C that is the vehicle resistance to flow during administration. The presence of a low concentration of xyloglucan (XYL) (0.25% w/w) increases the mucoadhesive properties and the capability to gelify at 37 °C of the formulation after dilution with SVF. A three-component (P407/MC/PEC; 3cM) and a four-component (P407/MC/PEC/XYL; 4cM) mixture were selected as promising candidates for the delivery of L. gasseri to the vaginal cavity. They were able to preserve L. gasseri viability and were cytocompatible towards the HeLa cell line. |
format | Online Article Text |
id | pubmed-6836057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68360572019-11-25 Development of a Mucoadhesive In Situ Gelling Formulation for the Delivery of Lactobacillus gasseri into Vaginal Cavity Vigani, Barbara Faccendini, Angela Rossi, Silvia Sandri, Giuseppina Bonferoni, Maria Cristina Grisoli, Pietro Ferrari, Franca Pharmaceutics Article Local administration of vaginal probiotics, especially lactobacilli, has been recently proposed as an effective prevention strategy against candidosis recurrences, which affect 40–50% of women. In this context, the aim of the present work was the development of a mucoadhesive in situ gelling formulation for the vaginal administration of Lactobacillus gasseri. Mixtures of poloxamer 407 (P407) and methylcellulose (MC), two thermosensitive polymers, were prepared and subjected to rheological analyses for the assessment of their sol/gel transition temperature. The association of P407 (15% w/w) with MC (1.5% w/w) produced an increase in gelation extent at 37 °C even after dilution in simulated vaginal fluid (SVF). The presence of 0.5% w/w pectin (PEC) produced a reduction of vehicle pH and viscosity at 25 °C that is the vehicle resistance to flow during administration. The presence of a low concentration of xyloglucan (XYL) (0.25% w/w) increases the mucoadhesive properties and the capability to gelify at 37 °C of the formulation after dilution with SVF. A three-component (P407/MC/PEC; 3cM) and a four-component (P407/MC/PEC/XYL; 4cM) mixture were selected as promising candidates for the delivery of L. gasseri to the vaginal cavity. They were able to preserve L. gasseri viability and were cytocompatible towards the HeLa cell line. MDPI 2019-10-03 /pmc/articles/PMC6836057/ /pubmed/31623341 http://dx.doi.org/10.3390/pharmaceutics11100511 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vigani, Barbara Faccendini, Angela Rossi, Silvia Sandri, Giuseppina Bonferoni, Maria Cristina Grisoli, Pietro Ferrari, Franca Development of a Mucoadhesive In Situ Gelling Formulation for the Delivery of Lactobacillus gasseri into Vaginal Cavity |
title | Development of a Mucoadhesive In Situ Gelling Formulation for the Delivery of Lactobacillus gasseri into Vaginal Cavity |
title_full | Development of a Mucoadhesive In Situ Gelling Formulation for the Delivery of Lactobacillus gasseri into Vaginal Cavity |
title_fullStr | Development of a Mucoadhesive In Situ Gelling Formulation for the Delivery of Lactobacillus gasseri into Vaginal Cavity |
title_full_unstemmed | Development of a Mucoadhesive In Situ Gelling Formulation for the Delivery of Lactobacillus gasseri into Vaginal Cavity |
title_short | Development of a Mucoadhesive In Situ Gelling Formulation for the Delivery of Lactobacillus gasseri into Vaginal Cavity |
title_sort | development of a mucoadhesive in situ gelling formulation for the delivery of lactobacillus gasseri into vaginal cavity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836057/ https://www.ncbi.nlm.nih.gov/pubmed/31623341 http://dx.doi.org/10.3390/pharmaceutics11100511 |
work_keys_str_mv | AT viganibarbara developmentofamucoadhesiveinsitugellingformulationforthedeliveryoflactobacillusgasseriintovaginalcavity AT faccendiniangela developmentofamucoadhesiveinsitugellingformulationforthedeliveryoflactobacillusgasseriintovaginalcavity AT rossisilvia developmentofamucoadhesiveinsitugellingformulationforthedeliveryoflactobacillusgasseriintovaginalcavity AT sandrigiuseppina developmentofamucoadhesiveinsitugellingformulationforthedeliveryoflactobacillusgasseriintovaginalcavity AT bonferonimariacristina developmentofamucoadhesiveinsitugellingformulationforthedeliveryoflactobacillusgasseriintovaginalcavity AT grisolipietro developmentofamucoadhesiveinsitugellingformulationforthedeliveryoflactobacillusgasseriintovaginalcavity AT ferrarifranca developmentofamucoadhesiveinsitugellingformulationforthedeliveryoflactobacillusgasseriintovaginalcavity |